These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12966599)

  • 1. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus.
    Constans J; Dupuy R; Blann AD; Resplandy F; Seigneur M; Renard M; Longy-Boursier M; Schaeverbeke T; Guérin V; Boisseau MR; Conri C
    J Rheumatol; 2003 Sep; 30(9):1963-6. PubMed ID: 12966599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-endothelial cell antibodies from lupus patients bind to apoptotic endothelial cells promoting macrophage phagocytosis but do not induce apoptosis.
    Williams JM; Colman R; Brookes CJ; Savage CO; Harper L
    Rheumatology (Oxford); 2005 Jul; 44(7):879-84. PubMed ID: 15827042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
    Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
    J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy.
    Mendonca LL; Khamashta MA; Cuadrado MJ; Bertolaccini ML; Hughes GR
    Arthritis Rheum; 2000 Jul; 43(7):1511-5. PubMed ID: 10902753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus.
    Montiel JL; Monsiváis-Urenda A; Figueroa-Vega N; Moctezuma JF; Burgos-Vargas R; González-Amaro R; Rosenstein Y
    Scand J Rheumatol; 2010; 39(1):50-7. PubMed ID: 20132071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.
    Dieudé M; Senécal JL; Raymond Y
    Arthritis Rheum; 2004 Oct; 50(10):3221-31. PubMed ID: 15476243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions.
    Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH
    Nephrology (Carlton); 2008 Dec; 13(8):712-20. PubMed ID: 18771467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage.
    Perry GJ; Elston T; Khouri NA; Chan TM; Cameron JS; Frampton G
    Q J Med; 1993 Nov; 86(11):727-34. PubMed ID: 8265773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.
    Carvalho D; Savage CO; Isenberg D; Pearson JD
    Arthritis Rheum; 1999 Apr; 42(4):631-40. PubMed ID: 10211876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
    van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN
    J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
    Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C
    J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies.
    Duval A; Helley D; Capron L; Youinou P; Renaudineau Y; Dubucquoi S; Fischer AM; Hachulla E
    Rheumatology (Oxford); 2010 Jun; 49(6):1049-55. PubMed ID: 20211868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.